158 related articles for article (PubMed ID: 7822013)
1. Pathogenicity of Saccharomyces cerevisiae in complement factor five-deficient mice.
Byron JK; Clemons KV; McCusker JH; Davis RW; Stevens DA
Infect Immun; 1995 Feb; 63(2):478-85. PubMed ID: 7822013
[TBL] [Abstract][Full Text] [Related]
2. Correlation of the frequency of petite formation by isolates of Saccharomyces cerevisiae with virulence.
Weger SD; Ganji A; Clemons KV; Byron JK; Minn Y; Stevens DA
Med Mycol; 2002 Apr; 40(2):161-8. PubMed ID: 12058729
[TBL] [Abstract][Full Text] [Related]
3. Comparative pathogenesis of clinical and nonclinical isolates of Saccharomyces cerevisiae.
Clemons KV; McCusker JH; Davis RW; Stevens DA
J Infect Dis; 1994 Apr; 169(4):859-67. PubMed ID: 8133102
[TBL] [Abstract][Full Text] [Related]
4. Colony phenotype switching in clinical and non-clinical isolates of Saccharomyces cerevisiae.
Clemons KV; Hanson LC; Stevens DA
J Med Vet Mycol; 1996; 34(4):259-64. PubMed ID: 8873885
[TBL] [Abstract][Full Text] [Related]
5. Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds.
Cerquetti MC; Sordelli DO; Bellanti JA; Hooke AM
Infect Immun; 1986 Jun; 52(3):853-7. PubMed ID: 3086235
[TBL] [Abstract][Full Text] [Related]
6. Impaired lung defenses against Staphylococcus aureus in mice with hereditary deficiency of the fifth component of complement.
Cerquetti MC; Sordelli DO; Ortegon RA; Bellanti JA
Infect Immun; 1983 Sep; 41(3):1071-6. PubMed ID: 6350178
[TBL] [Abstract][Full Text] [Related]
7. Impaired insulin signaling in the B10.D2-
Peterson KR; Gutierrez DA; Kikuchi T; Anderson-Baucum EK; Winn NC; Shuey MM; Bolus WR; McGuinness OP; Hasty AH
Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E200-E211. PubMed ID: 31084499
[TBL] [Abstract][Full Text] [Related]
8. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
Cunnion KM; Benjamin DK; Hester CG; Frank MM
J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
[TBL] [Abstract][Full Text] [Related]
9. Role of complement C5 and T lymphocytes in pathogenesis of disseminated and mucosal candidiasis in susceptible DBA/2 mice.
Ashman RB; Papadimitriou JM; Fulurija A; Drysdale KE; Farah CS; Naidoo O; Gotjamanos T
Microb Pathog; 2003 Feb; 34(2):103-13. PubMed ID: 12623278
[TBL] [Abstract][Full Text] [Related]
10. Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions.
Pasinetti GM; Tocco G; Sakhi S; Musleh WD; DeSimoni MG; Mascarucci P; Schreiber S; Baudry M; Finch CE
Neurobiol Dis; 1996; 3(3):197-204. PubMed ID: 8980020
[TBL] [Abstract][Full Text] [Related]
11. Experimental Toxoplasma gondii infection in mice: the role of the fifth component of complement.
Araujo FG; Rosenberg LT; Remington JS
Proc Soc Exp Biol Med; 1975 Jul; 149(3):800-4. PubMed ID: 1144466
[TBL] [Abstract][Full Text] [Related]
12. Trypanosoma musculi infections in normocomplementemic, C5-deficient, and C3-depleted mice.
Jarvinen JA; Dalmasso AP
Infect Immun; 1977 May; 16(2):557-63. PubMed ID: 863515
[TBL] [Abstract][Full Text] [Related]
13. Severe and prolonged inflammatory response to localized cowpox virus infection in footpads of C5-deficient mice: investigation of the role of host complement in poxvirus pathogenesis.
Miller CG; Justus DE; Jayaraman S; Kotwal GJ
Cell Immunol; 1995 May; 162(2):326-32. PubMed ID: 7743560
[TBL] [Abstract][Full Text] [Related]
14. A role for complement C5 in organism containment and granulomatous response during murine tuberculosis.
Actor JK; Breij E; Wetsel RA; Hoffmann H; Hunter RL; Jagannath C
Scand J Immunol; 2001 May; 53(5):464-74. PubMed ID: 11309154
[TBL] [Abstract][Full Text] [Related]
15. A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis.
Wang Y; Kristan J; Hao L; Lenkoski CS; Shen Y; Matis LA
J Immunol; 2000 Apr; 164(8):4340-7. PubMed ID: 10754334
[TBL] [Abstract][Full Text] [Related]
16. In vivo virulence of commercial Saccharomyces cerevisiae strains with pathogenicity-associated phenotypical traits.
de Llanos R; Llopis S; Molero G; Querol A; Gil C; Fernández-Espinar MT
Int J Food Microbiol; 2011 Jan; 144(3):393-9. PubMed ID: 21081253
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5'-exon.
Wetsel RA; Fleischer DT; Haviland DL
J Biol Chem; 1990 Feb; 265(5):2435-40. PubMed ID: 2303408
[TBL] [Abstract][Full Text] [Related]
18. Role of IgG and complement component C5 in the initial course of experimental cryptococcosis.
Dromer F; Perronne C; Barge J; Vilde JL; Yeni P
Clin Exp Immunol; 1989 Dec; 78(3):412-7. PubMed ID: 2612053
[TBL] [Abstract][Full Text] [Related]
19. Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shock.
Barton PA; Warren JS
Infect Immun; 1993 Apr; 61(4):1474-81. PubMed ID: 8454352
[TBL] [Abstract][Full Text] [Related]
20. C5 does not play a major role in the immune response of mice to SRBC in vivo.
van den Berg CW; van Horssen PJ; Hofhuis FM; Aerts PC; van Dijk H
Scand J Immunol; 1991 May; 33(5):621-6. PubMed ID: 2031152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
